NR 565 MIDTERM EXAM V3 ADVANCED
PHARMACOLOGY TEST BANK (QUESTIONS,
ANSWERS & RATIONALES)
This premium study bank features comprehensive, board-
style practice questions with bold rationales designed to
ensure mastery of high-yield advanced pharmacology
concepts. It mirrors the exact clinical scenarios, drug-
interaction traps, and prescriptive authority regulations
tested on advanced practice nursing midterms and final
exams. Ideal for students seeking top marks, this resource
provides the ultimate preparation tool to confidently pass
challenging pharmacology assessments.
1. A 64-year-old male with a history of severe chronic
obstructive pulmonary disease (COPD) and chronic heart
failure requires a beta-blocker. Which medication is most
appropriate?
A) Propranolol
B) Nadolol
C) Metoprolol succinate
D) Timolol
• Answer: C
• Rationale: Metoprolol succinate is a cardioselective
beta-1 adrenergic antagonist. At therapeutic doses, it
, preferentially blocks beta-1 receptors in the heart rather
than beta-2 receptors in the bronchioles, making it safer
for patients with bronchospastic disease like COPD
compared to non-selective agents like propranolol or
nadolol.
2. A patient is prescribed digoxin for heart failure. Which
electrolyte imbalance most significantly increases the risk of
digoxin toxicity?
A) Hyperkalemia
B) Hypokalemia
C) Hypernatremia
D) Hyponatremia
• Answer: B
• Rationale: Digoxin binds to the sodium-potassium
ATPase pump by competing for the same binding site as
potassium. When extracellular potassium levels are low
(hypokalemia), digoxin binds more easily and firmly to
the pump, drastically increasing its therapeutic effect
and precipitating toxicity even at normal serum digoxin
levels.
3. An absolute contraindication to the initiation of an
Angiotensin-Converting Enzyme (ACE) inhibitor is:
A) Hyperkalemia greater than 4.0 mEq/L
B) History of angioedema
C) Concomitant use of a thiazide diuretic
D) Stage 2 chronic kidney disease
• Answer: B
, • Rationale: A history of angioedema—whether idiopathic,
hereditary, or previously induced by an ACE inhibitor—
is a strict, life-threatening contraindication due to the
increased accumulation of bradykinin, which can lead to
fatal airway obstruction.
4. When initiating a HMG-CoA reductase inhibitor (statin), the
nurse practitioner must counsel the patient to report which
symptom immediately?
A) Mild headache
B) Unexplained muscle pain or weakness
C) Transient nausea
D) Increased flatulence
• Answer: B
• Rationale: Unexplained muscle pain, tenderness, or
weakness can be an early sign of statin-induced
myopathy or rhabdomyolysis. Prompt evaluation of
serum creatine kinase (CK) levels is necessary to
prevent severe renal damage.
5. A patient taking warfarin is prescribed amiodarone. What
adjustment should be anticipated for the warfarin dosage?
A) Increase the warfarin dose by 50%
B) Decrease the warfarin dose by 30% to 50%
C) Keep the warfarin dose the same but double the target INR
D) Discontinue warfarin and switch to low-molecular-weight
heparin immediately
• Answer: B
• Rationale: Amiodarone is a potent inhibitor of CYP2C9,
the primary metabolic pathway for the active isomer of
, warfarin. Initiating amiodarone will rapidly increase
serum warfarin concentrations and elevate the INR,
necessitating a proactive dose reduction of warfarin.
6. Which mechanism describes how low-molecular-weight
heparins (LMWHs) differ from unfractionated heparin (UFH)?
A) LMWHs preferentially inhibit Factor Xa over Factor IIa
(thrombin)
B) LMWHs require routine aPTT monitoring
C) LMWHs have a significantly shorter half-life than UFH
D) LMWHs are administered via continuous intravenous infusion
only
• Answer: A
• Rationale: Due to their smaller molecular chain length,
LMWHs possess a higher ratio of anti-Factor Xa to anti-
Factor IIa activity compared to unfractionated heparin,
allowing for a more predictable anticoagulant response
that does not routinely require laboratory monitoring.
7. A patient presents with classic signs of an acute gout flare.
Which agent is preferred for first-line abortive therapy
assuming normal renal function?
A) Allopurinol
B) Febuxostat
C) Indomethacin
D) Probenecid
• Answer: C
• Rationale: Nonsteroidal anti-inflammatory drugs
(NSAIDs) such as indomethacin, or systemic
corticosteroids and colchicine, are the mainstays for
PHARMACOLOGY TEST BANK (QUESTIONS,
ANSWERS & RATIONALES)
This premium study bank features comprehensive, board-
style practice questions with bold rationales designed to
ensure mastery of high-yield advanced pharmacology
concepts. It mirrors the exact clinical scenarios, drug-
interaction traps, and prescriptive authority regulations
tested on advanced practice nursing midterms and final
exams. Ideal for students seeking top marks, this resource
provides the ultimate preparation tool to confidently pass
challenging pharmacology assessments.
1. A 64-year-old male with a history of severe chronic
obstructive pulmonary disease (COPD) and chronic heart
failure requires a beta-blocker. Which medication is most
appropriate?
A) Propranolol
B) Nadolol
C) Metoprolol succinate
D) Timolol
• Answer: C
• Rationale: Metoprolol succinate is a cardioselective
beta-1 adrenergic antagonist. At therapeutic doses, it
, preferentially blocks beta-1 receptors in the heart rather
than beta-2 receptors in the bronchioles, making it safer
for patients with bronchospastic disease like COPD
compared to non-selective agents like propranolol or
nadolol.
2. A patient is prescribed digoxin for heart failure. Which
electrolyte imbalance most significantly increases the risk of
digoxin toxicity?
A) Hyperkalemia
B) Hypokalemia
C) Hypernatremia
D) Hyponatremia
• Answer: B
• Rationale: Digoxin binds to the sodium-potassium
ATPase pump by competing for the same binding site as
potassium. When extracellular potassium levels are low
(hypokalemia), digoxin binds more easily and firmly to
the pump, drastically increasing its therapeutic effect
and precipitating toxicity even at normal serum digoxin
levels.
3. An absolute contraindication to the initiation of an
Angiotensin-Converting Enzyme (ACE) inhibitor is:
A) Hyperkalemia greater than 4.0 mEq/L
B) History of angioedema
C) Concomitant use of a thiazide diuretic
D) Stage 2 chronic kidney disease
• Answer: B
, • Rationale: A history of angioedema—whether idiopathic,
hereditary, or previously induced by an ACE inhibitor—
is a strict, life-threatening contraindication due to the
increased accumulation of bradykinin, which can lead to
fatal airway obstruction.
4. When initiating a HMG-CoA reductase inhibitor (statin), the
nurse practitioner must counsel the patient to report which
symptom immediately?
A) Mild headache
B) Unexplained muscle pain or weakness
C) Transient nausea
D) Increased flatulence
• Answer: B
• Rationale: Unexplained muscle pain, tenderness, or
weakness can be an early sign of statin-induced
myopathy or rhabdomyolysis. Prompt evaluation of
serum creatine kinase (CK) levels is necessary to
prevent severe renal damage.
5. A patient taking warfarin is prescribed amiodarone. What
adjustment should be anticipated for the warfarin dosage?
A) Increase the warfarin dose by 50%
B) Decrease the warfarin dose by 30% to 50%
C) Keep the warfarin dose the same but double the target INR
D) Discontinue warfarin and switch to low-molecular-weight
heparin immediately
• Answer: B
• Rationale: Amiodarone is a potent inhibitor of CYP2C9,
the primary metabolic pathway for the active isomer of
, warfarin. Initiating amiodarone will rapidly increase
serum warfarin concentrations and elevate the INR,
necessitating a proactive dose reduction of warfarin.
6. Which mechanism describes how low-molecular-weight
heparins (LMWHs) differ from unfractionated heparin (UFH)?
A) LMWHs preferentially inhibit Factor Xa over Factor IIa
(thrombin)
B) LMWHs require routine aPTT monitoring
C) LMWHs have a significantly shorter half-life than UFH
D) LMWHs are administered via continuous intravenous infusion
only
• Answer: A
• Rationale: Due to their smaller molecular chain length,
LMWHs possess a higher ratio of anti-Factor Xa to anti-
Factor IIa activity compared to unfractionated heparin,
allowing for a more predictable anticoagulant response
that does not routinely require laboratory monitoring.
7. A patient presents with classic signs of an acute gout flare.
Which agent is preferred for first-line abortive therapy
assuming normal renal function?
A) Allopurinol
B) Febuxostat
C) Indomethacin
D) Probenecid
• Answer: C
• Rationale: Nonsteroidal anti-inflammatory drugs
(NSAIDs) such as indomethacin, or systemic
corticosteroids and colchicine, are the mainstays for
